FDA Guidance on Conduct of Clinical Trials of Medical Products During the Public Health Emergency
The Four Phases of Clinical Trials | Diversity in Clinical Trials | AKF
Most Common Issues with CDISC-SEND Data in FDA Toxicology Review – Sep. 12, 2019
FDA Regulatory Requirements for Clinical Investigators and Case Examples (9of14) REdI 2018
FDA Webinar on the Infant Formula Transition Plan for Exercise of Enforcement Discretion (Part 1)
Regulatory and Clinical Trials for Therapeutics
June 17, 2021- Introduction to FDA: History, Regulations, and Clinical Trial Design
Walkthrough of an FDA Clinical Investigator Site Inspection (12/14) REdI 2017
Everything You Need to Know About the RSV Vaccine and Antibody
Investigator Responsibilities - Safety Reporting for Investigational Drugs and Devices
Overview of Postmarketing Drug Safety Reporting Requirements - REdI 2020
FDA EMA immunogenicity guidelines APR2020
What is Safety Reporting in Clinical Trials?
FDA Study Data Technical Rejection Criteria (TRC): What you need to know!
Diversity in Clinical Trials: Learn about Enrollment Trends and Resources from FDA
Industry Panel Insights on FDA's Guidance and Inclusive Clinical Trials
OTC Monograph Reform: OMOR Format and Content & Electronic Submissions
Serious Adverse Event Reporting for Investigators
Webinar — Comparing CTA Submission (EMA/Health Canada) to IND Applications (FDA) for Phase I Trials
FDA Study Data Technical Conformance Guide v4.4 - Nov 22, 2019
